Patents/Assignees

Rottapharm Biotech S.R.L.

6 patents in portfolio

US12544365utility2026
Pharmaceutical Combination of an EP4 Antagonist and Immune Checkpoint Inhibitors for the Treatment of Tumours
0 cites
US12509446utility2025
FYN and VEGFR2 Kinase Inhibitors
0 cites
US12433875utility2025
(r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) Benzoic Acid or Its Salt Also in Polymorphic Form a for Use in the Prevention of Heterotopic Ossification
0 cites
US12404245utility2025
Process for the Preparation of (r)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) Benzoic Acid or a Salt Thereof
0 cites
US11718582utility2023
(r)-4-(1-(1-(4-(trifluoromethyl)benzyl)pyrrolidine-2-carboxamide)cyclopropyl)-benzoic Acid as EP4 Receptor Antagonist
0 cites
US11590114utility2023
Pharmaceutical Combination of an EP4 Antagonist and Immune Checkpoint Inhibitors for the Treatment of Tumours
0 cites